ANTIBACTERIAL PREDRUGS-FROM 1899 TILL 2015

No abstract is available for this paper.

• Publication year

  2015

• Venue

  World journal of Pharmacy and pharmaceutical sciences

• Publication date

  2015-07-08

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MEFENAMIC ACID PRODRUGS AND CODRUGS-TWO DECADES OF DEVELOPMENT

  2016cited by this paper
• Prodrugs—An Overview

  2016cited by this paper
• DESIGN OF PRODRUGS TO REPLACE COMMONLY USED DRUGS HAVING BITTER SENSATION

  2015cited by this paper
• Anti-cancer Prodrugs-Three Decades of Design

  2015cited by this paper
• From Conventional Prodrugs to Prodrugs Designed by Molecular Orbital Methods

  2015cited by this paper
• DICLOFENAC CODRUGS AND PRODRUGS-THREE DECADES OF DESIGN

  2015cited by this paper
• Prodrugs for Masking the Bitter Taste of Drugs

  2014cited by this paper
• Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations

  2014cited by this paper
• Computationally designed atovaquone prodrugs based on Bruice's enzyme model.

  2014cited by this paper
• Using predrugs to optimize drug candidates

  2014cited by this paper
• Prodrug Design by Computation Methods: A New Era

  2013cited by this paper
• Computationally-designed phenylephrine prodrugs – a model for enhancing bioavailability

  2013cited by this paper
• The Prodrug Naming Dilemma

  2013cited by this paper
• The future of prodrugs – design by quantum mechanics methods

  2013cited by this paper
• Prodrug Design vs. Drug Design

  2013cited by this paper
• A Solution to Aversive Tasting Drugs for Pediatric and Geriatric Patients

  2013cited by this paper
• Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions

  2013cited by this paper
• Prodrugs for masking bitter taste of antibacterial drugs—a computational approach

  2013cited by this paper
• Computationally designed prodrugs of statins based on Kirby’s enzyme model

  2013cited by this paper
• Computationally Designed Enzyme Models To Replace Natural Enzymes In Prodrug Approaches

  2012cited by this paper
• Computationally Designed Prodrugs for Masking the Bitter Taste of Drugs

  2012cited by this paper
• Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach

  2012cited by this paper
• Prodrugs of Acyclovir – A Computational Approach

  2012cited by this paper
• Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis—a computational approach

  2012cited by this paper
• The Future of Prodrugs Designed by Computational Chemistry

  2012cited by this paper
• Computer-assisted design for atenolol prodrugs for the use in aqueous formulations

  2012cited by this paper
• Analyzing Kemp’s amide cleavage: A model for amidase enzymes

  2011cited by this paper
• Analyzing the efficiency in intramolecular amide hydrolysis of Kirby’s N-alkylmaleamic acids – A computational approach

  2011cited by this paper
• The role of proximity orientation in intramolecular proton transfer reactions

  2011cited by this paper
• Analyzing the efficiency of proton transfer to carbon in Kirby's enzyme model—a computational approach

  2011cited by this paper
• Computational‐Aided Design for Dopamine Prodrugs Based on Novel Chemical Approach

  2011cited by this paper
• Computer-assisted design for paracetamol masking bitter taste prodrugs

  2011cited by this paper
• Proximity vs. strain in intramolecular ring-closing reactions

  2010cited by this paper
• Prodrugs of aza nucleosides based on proton transfer reaction

  2010cited by this paper
• Computer-assisted design of pro-drugs for antimalarial atovaquone.

  2010cited by this paper
• The effective molarity (EM)--a computational approach.

  2010cited by this paper
• A singularity model for chemical reactivity.

  2010cited by this paper
• A computational analysis of intramolecularity in proton transfer reactions.

  2010cited by this paper
• Prodrugs available on the Brazilian pharmaceutical market and their corresponding bioactivation pathways

  2010cited by this paper
• From Enzyme Models to Model Enzymes

  2010cited by this paper
• The efficiency of proton transfer in Kirby’s enzyme model, a computational approach

  2010cited by this paper
• A general equation correlating intramolecular rates with ‘attack’ parameters: distance and angle

  2010cited by this paper
• Effects of substitution on the effective molarity (EM) for five membered ring-closure reactions – A computational approach

  2010cited by this paper
• The effective molarity (EM) puzzle in intramolecular ring-closing reactions

  2010cited by this paper
• From Enzyme Models to Model Enzymes

  2010cited by this paper
• Cleavage of Menger’s aliphatic amide: A model for peptidase enzyme solely explained by proximity orientation in intramolecular proton transfer

  2009cited by this paper
• Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility

  2009cited by this paper
• The effective molarity (EM) puzzle in proton transfer reactions.

  2009cited by this paper
• The gem-disubstituent effect—a computational study that exposes the relevance of existing theoretical models

  2009cited by this paper
• Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.

  2009cited by this paper
• Analyzing Kirby's amine olefin-a model for amino acid ammonia lyases

  2009cited by this paper
• Accelerations in the Lactonization of Trimethyl Lock Systems Are due to Proximity Orientation and not to Strain Effects

  2009cited by this paper
• A new mathematical equation relating activation energy to bond angle and distance: A key for understanding the role of acceleration in lactonization of the trimethyl lock system.

  2009cited by this paper
• Reevaluation of Bruice’s proximity orientation

  2009cited by this paper
• Prodrugs: design and clinical applications

  2008cited by this paper
• Analysis of Menger’s ‘spatiotemporal hypothesis’

  2008cited by this paper
• Prodrug strategies to overcome poor water solubility.

  2007cited by this paper
• Enzymes involved in the bioconversion of ester-based prodrugs.

  2006cited by this paper
• Efficient intramolecular general acid catalysis of nucleophilic attack on a phosphodiester.

  2006cited by this paper
• Mutual prodrug concept: Fundamentals and applications

  2006cited by this paper
• An alternative view of enzyme catalysis

  2005cited by this paper
• Relationship between rate and distance.

  2003cited by this paper
• Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

  2001cited by this paper
• A mechanism for efficient proton-transfer catalysis. Intramolecular general acid catalysis of the hydrolysis of 1-arylethyl ethers of salicylic acid

  1999cited by this paper
• Clinical efficacy of Velac®, a new tretinoin and clindamycin phosphate gel in acne vulgaris

  1998cited by this paper
• Exploring the Limits of Efficiency of Proton-Transfer Catalysis in Models and Enzymes

  1997cited by this paper
• Antibody-enzyme conjugates for cancer therapy.

  1996cited by this paper
• Enzyme Mechanisms, Models, and Mimics

  1996cited by this paper
• Efficient intramolecular general acid catalysis of enol ether hydrolysis. Hydrogen-bonding stabilisation of the transition state for proton transfer to carbon

  1994cited by this paper
• Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

  1994cited by this paper
• Symmetrical and unsymmetrical quadruply aza-bridged closely interspaced cofacial bis(5,10,15,20-tetraphenylporphyrins). 4. Structure and conformational effects on electrochemistry and the catalysis of electrochemical reduction of dioxygen by doubly, triply, and quadruply N,N-dimethylene sulfonamide

  1993cited by this paper
• Symmetrical and unsymmetrical quadruply aza bridged closely interspaced cofacial bis(5,10,15,20-tetraphenylporphyrins). 3. Interplanar distances, proton NMR chemical shifts, and the catalysis of the electrochemical reduction of oxygen

  1992cited by this paper
• Symmetrical and unsymmetrical quadruply aza-bridged, closely interspaced, cofacial bis(5,10,15,20-tetraphenylporphyrin)s. 2. Synthesis, characterization, and conformational effects of solvents

  1992cited by this paper
• Kinetic Importance of Conformations of Nicotinamide Adenine Dinucleotide in the Reactions of Dehydrogenase Enzymes

  1992cited by this paper
• Unusual behavior of 5,10,15,20-tetraphenylporphine diacid toward oxygen Broensted bases

  1992cited by this paper
• Efficient intramolecular general acid catalysis of vinyl ether hydrolysis by the neighbouring carboxylic acid group

  1991cited by this paper
• Synthesis and Characterization of the First Water-Soluble Closely Interspaced Cofacial Porphyrin Dimer.

  1991cited by this paper
• Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans.

  1990cited by this paper
• Fast hydrolysis of an aliphatic amide at neutral pH and ambient temperature. A peptidase model

  1988cited by this paper
• On the source of intramolecular and enzymatic reactivity

  1985cited by this paper
• Pharmacokinetics of sultamicillin in mice, rats, and dogs

  1984cited by this paper
• Directionality of proton transfer in solution. Three systems of known angularity

  1983cited by this paper
• The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

  1982cited by this paper
• Intramolecular general acid catalysis in the hydrolysis of acetals with aliphatic alcohol leaving groups

  1979cited by this paper
• Pharmacokinetics of carfecillin and carindacillin.

  1977cited by this paper
• Kinetic approach to the development in beta-lactam antibiotics. II. Prodrug. (I). Simultaneous determination of hetacillin and ampicillin, and its application to the stability of hetacillin in aqueous solutions.

  1974cited by this paper
• Comparison of ampicillin and hetacillin pharmacokinetics in man.

  1973cited by this paper
• Distribution studies of salicylazosulfapyridine and its metabolites.

  1973cited by this paper
• The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.

  1972cited by this paper
• Parenteral development of clindamycin-2-phosphate.

  1972cited by this paper
• Structure and efficiency in intramolecular and enzymic catalysis. Catalysis of amide hydrolysis by the carboxy-group of substituted maleamic acids

  1972cited by this paper
• Parenteral development of clindamycin-2-phosphate.

  1972cited by this paper
• Relative stability of hetacillin and ampicillin in solution.

  1972cited by this paper
• Local and systemic tolerance, absorption and excretion of clindamycin hydrochloride after intramuscular administration.

  1970cited by this paper
• SOME NOVEL PENICILLIN DERIVATIVES.

  1965cited by this paper
• 379. Some novel penicillin derivatives

  1965cited by this paper
• Chemical Aspects of Selective Toxicity

  1958cited by this paper
• Succinic acid esters of chloramphenicol.

  1957cited by this paper

• Identification, Characterization, and Preliminary X-ray Diffraction Analysis of a Novel Esterase (ScEst) from Staphylococcus chromogenes

  2022cites this paper